Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed

(2015) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Current and Emerging Biologics for Ulcerative Colitis

(2015) Sung Chul Park et al.   Gut and Liver

Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of Response

(2015) Christopher Ma et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice

(2015) Anita Bálint et al.   Journal of Crohns & Colitis

Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort study

(2015) Katrine Risager Christensen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Biological therapy for ulcerative colitis: An update

(2014) Geom Seog Seo   WORLD JOURNAL OF GASTROENTEROLOGY

Review article: immunogenicity of anti-TNF biologics in IBD - the role of patient, product and prescriber factors

(2013) A. C. Moss et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

(2013) Yasuo Suzuki et al.   JOURNAL OF GASTROENTEROLOGY

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Clinical experience with adalimumab in anti-TNF-naïve patients with ulcerative colitis

(2012) David Busquets et al.   Journal of Crohns & Colitis

Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis

(2012) Edel McDermott et al.   Journal of Crohns & Colitis

Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome

(2012) Orlando García-Bosch et al.   Journal of Crohns & Colitis

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2011) William J. Sandborn et al.   GASTROENTEROLOGY

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

(2011) W. Reinisch et al.   GUT

Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab

(2010) C. Taxonera et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the costs of ulcerative colitis in Western countries

(2010) R. D. COHEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort

(2010) N. Gies et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

“How to Manage Loss of Response to Anti-TNF in Crohns Disease?”

(2010) Walter Reinisch   CURRENT DRUG TARGETS

Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab

(2009) C. MA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab

(2009) Waqqas Afif et al.   INFLAMMATORY BOWEL DISEASES

Adalimumab in ulcerative colitis: Two cases of mucosal healing and clinical response at two years

(2009) Manuel Barreiro-de Acosta et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience

(2008) A. OUSSALAH et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Onset of Ulcerative Colitis Under Treatment With Adalimumab

(2008)   AMERICAN JOURNAL OF GASTROENTEROLOGY